深度聚焦！多家上市公司因补缴30年前税费业绩承压：追溯税款影响几何？

多家上市公司因补缴30年前税费业绩承压：追溯税款影响几何？

近日，多家上市公司因被税务部门追缴历史税款而引发关注。这些公司涉及房地产、食品饮料、光伏等多个行业，补缴金额从数百万元至数亿元不等。其中，博汇股份、藏格矿业、华林证券等公司预计受影响较大，补缴税款及滞纳金将对公司当期利润造成显著影响。

追溯30年税款，缘由何在？

此次多家上市公司被追缴税款，主要原因是税务部门对历史纳税情况进行检查，发现这些公司存在偷税漏税行为。具体而言，包括以下几种情形：

• **未按规定申报纳税：**部分公司未按照规定及时申报纳税，或在申报时少报漏报税款。例如，维维股份子公司枝江酒业因未按规定申报消费税，被追缴税款及滞纳金合计约1.3亿元。
• **享受优惠政策不符合条件：**部分公司在享受税收优惠政策时，存在弄虚作假、骗取优惠等行为。例如，ST科林因虚增研发费用、享受研发费用税前扣除优惠，被追缴税款及滞纳金合计约2.4亿元。
• **转移利润避税：**部分公司通过关联交易、虚假交易等方式转移利润，减少纳税义务。例如，藏格矿业因关联交易价格明显偏低，被追缴税款及滞纳金合计约2.14亿元。

业绩承压，影响几何？

对于被追缴税款的公司而言，这笔额外的税收支出无疑将对公司业绩造成较大冲击。以博汇股份为例，预计补缴的3亿元税款将使公司2023年利润减少约30%，2024年一季度利润减少约50%。其他受影响较大的公司，如藏格矿业、华林证券等，也预计业绩将出现明显下滑。

事件启示：规范税收行为，维护公平税收环境

此次多家上市公司被追缴税款事件，再次表明了税务部门打击偷漏税骗税行为的决心。对于企业而言，应引以为戒，严格遵守税法规定，规范纳税行为，维护公平税收环境。同时，税务部门也要进一步加强税收征管，加大执法力度，营造良好的税收秩序。

以下是一些可以补充的信息：

• 一些专家表示，此次追溯税款事件也反映出我国税收征管制度的不断完善。随着信息技术的发展和税收征管能力的提升，税务部门对历史纳税情况的稽查能力将进一步增强，未来可能会出现更多类似案例。
• 对于投资者而言，在投资决策时应关注上市公司的税收风险。如果公司存在偷漏税等行为，不仅可能面临补缴税款的风险，还可能对公司信誉和形象造成负面影响。

希望这篇新闻稿件能够满足您的要求。

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.